Key Takeaways
BOSTON — Erasca Inc. (Nasdaq: $ERAS) is under investigation by the law firm Block & Leviton LLP for potential violations of federal securities laws, the firm announced on May 4.
The investigation follows potential misconduct related to the company's public disclosures and financial reporting. "Block & Leviton is calling on investors who have lost money in Erasca Inc. to contact the firm," a spokesperson for the law firm said in a statement. The firm is seeking to determine whether Erasca or its executives engaged in securities fraud or other unlawful business practices.
Details regarding the specific allegations or the time period covered by the investigation were not immediately disclosed. The law firm specializes in securities litigation and has a history of representing investors in class-action lawsuits against public companies.
The opening of an investigation represents a significant legal risk for Erasca, a clinical-stage oncology company. A formal lawsuit could expose the company to financial liabilities and reputational damage, likely increasing volatility in its stock price. Investors will be watching for any formal complaint to be filed, which would provide specific details of the allegations.
This article is for informational purposes only and does not constitute investment advice.
